Published on 29 Nov 2023 on Simply Wall St. via Yahoo Finance
Retail investors are Vistagen Therapeutics, Inc.'s (NASDAQ:VTGN) biggest owners and were rewarded...
Key Insights
Significant control over Vistagen Therapeutics by retail investors implies that the general public has more power to influence management and governance-related decisionsThe top 25 shareholders own 41% of the company Institutional ownership in Vistagen Therapeutics is 12%
Every investor in Vistagen Therapeutics, Inc. (NASDAQ:VTGN) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the company with 59% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.